Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Gliadel successfully completes mutual recognition procedure in 10 E.U. countries

June 25, 1999

Bristol-Myers Squibb files for FDA approval of Taxol/Herceptin combination

June 25, 1999

GlycoDesign expands GD0039 phase II cancer trial to additional site

June 24, 1999

Does melatonin improve the tolerability of chemotherapy?

June 24, 1999

Cell Pathways completes phase III APC trial analysis

June 24, 1999

U.K. is first market for new formulation of Casodex

June 23, 1999

Anti-VEGF antibody reverses ascites associated with ovarian cancer in rodent model

June 22, 1999

Sustained-release formulation of GnRH antagonist assessed for PD/PK in dogs

June 21, 1999

Lead GnRH antagonist presented at Endocrine Society meeting by Abbott, TAP

June 21, 1999

New paclitaxel derivatives with broad anticancer activity developed at Xechem

June 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...